SETLNSE6 November 2025

Standard Glass Lining Technology Limited has informed the Exchange about Investor Presentation

Standard Engineering Technology Limited

Date: November 06, 2025

To, Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001

Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C-1 Block G, Bandra - Kurla Complex, Bandra (East) Mumbai - 400 051

SCRIP CODE: 544333

SYMBOL: SGLTL

Dear Sir/Madam,

Sub: Investor Presentation on the Financial Results for the quarter and half year ended September 30, 2025

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Investor Presentation on the Financial Results for the quarter and half year ended September 30 2025.

You are requested to kindly take the above information on record.

Thanking you,

Yours faithfully,

For STANDARD GLASS LINING TECHONOLOGY LIMITED

Kallam Hima Priya Company Secretary & Compliance Officer

Enclosure: A/a

Standard Glass Lining Technology Limited

Registered office: D-12, Phase-I, IDA Jeedimetla, Hyderabad -500055 Corporate Office: 10th Floor, PNR High Nest, Hydernagar, KPHB Colony, Hyderabad- 500085 Manufacturing Unit: Survey No. 42/A, Alinagar, Chetlapotharam Village, Gaddapotharam, SangaReddy- 501319

CIN: L29220TG2012PLC082904 Email: corporate@standardglr.com Website: www.standardglr.com Tel: + 040 3518 2204

Standard Glass Lining Technology Limited

Investor Presentation

November 2025

Disclaimer

This presentation and the accompanying slides (the “Presentation”), have been prepared by Standard Glass Lining Technology Limited (the “Company”) solely for information purposes and do not constitute any offer, recommendation, or invitation to purchase or subscribe for any securities and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.

Certain statements in this presentation concerning our future growth prospects are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The Risk and uncertainties relating to the statements include but are not limited to, risks and uncertainties regarding fiscal policy, competition, inflationary pressures, climate and general economic conditions affecting demand/supply and price conditions in domestic and international markets. The Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.

This Presentation has been prepared by the Company based on information and data which the Company considers reliable. This Presentation may not be all-inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. The Company does not make any promise to update/provide such a presentation along with results to be declared in the coming quarters and years.

‹#›2

Table of Content

Quarter Performance Q2FY26

Business Overview

Annexure

3 ‹#›

QUARTER PERFORMANCE- Q2FY26

BUSINESS OVERVIEW

ANNEXURE

A Message from the MD

“

”Our second quarter demonstrates continued strong sales growth and healthy financial performance. More importantly, this period marks a transformation in our journey—from Standard Glass Lining Technology Limited to the proposed Standard Engineering Technology Limited—signifying our transition into a concept-to- commissioning precision engineering enterprise.

The acquisitions of Scigenics and C2C Engineering strengthen our end-to-end capabilities and global relevance. We are confident that our unique integration of design, manufacturing and commissioning skills will propel us toward sustainable growth and long-term value creation for our investors, customers and all stakeholders.”

Promoter and Managing Director

“

5 ‹#›

COO’s Comment

“

“We are pleased with our strong first-half performance, which underscores the resilience of our core businesses and the success of our strategic initiatives. The integration of Scigenics and the proposed acquisition of C2C Engineering mark important milestones in our journey toward becoming a complete concept-to-commissioning solutions provider.

With a healthy order pipeline, robust export demand, and expanding capabilities across biotechnology and process industries, we are well positioned for sustained growth and enhanced operational excellence in the coming quarters.”

Promoter and Executive Director

“

6 ‹#›

Strategic and Business Updates

Scigenics (India) Pvt. Ltd.

C2C Engineering Pvt. Ltd.

Proposed Change in Name & Object

• Standard Scigenics Pvt. Ltd., a subsidiary of the Company, signed Definitive Agreements on October 31, 2025, to acquire the business of Scigenics (India) Pvt. Ltd. on a slump sale basis for a cash consideration of ₹9 crore.

• Scigenics (India) Pvt. Ltd is engaged in

manufacturing of process and bioprocess equipment for biotech, pharma, and chemical industries

• The acquisition integrates 34+ years of

bioreactor expertise with proven engineering excellence, enhancing innovation and operational capabilities.

• SGLTL to acquire 51% stake in C2C Engineering Pvt. Ltd. (binding term sheet signed on Nov 3, 2025).

• Chennai-based C2C, a multidisciplinary EPC

and consulting firm with ~20 years’ experience across multiple engineering domains.

• Strengthens front-end design and engineering

capabilities, complementing SGLTL’s manufacturing and turnkey execution expertise.

• Enables end-to-end, concept-to-

commissioning solutions, driving faster execution, efficiency, and innovation across key industries.

• On October 30, 2025, the Company received

Registrar of Companies approval for availability of the new name “Standard Engineering Technology Limited.”

• The name change will be implemented upon completion of statutory and shareholder approvals.

• Board proposed amendment to the Objects Clause to align with the Company’s evolving business direction and future growth strategy.

• Revised scope to cover high-precision

engineering, advanced manufacturing, and turnkey solutions across industries— reflecting its transformation into a diversified, future-ready technology solutions provider.

7 ‹#›

Earnings at Glance: H1 & Q2 FY26

Total Income

EBITDA

PBT

PAT

H1FY26

Q2FY26

₹ 366 Cr ▲ 17.4% YoY

₹ 188 Cr ▲ 5.6% QoQ

₹ 69 Cr ▲ 9.6% YoY

₹ 34 Cr ▼ 1.8% QoQ

₹ 56 Cr ▲ 13.0% YoY

₹ 28 Cr ▼ 2.7% QoQ

₹ 42 Cr ▲ 14.6% YoY

₹ 20 Cr ▼ 3.2% QoQ

Sales growth during the quarter was driven by timely execution and delivery of key projects

Export dispatches of ₹40–45 Cr were deferred to Q3–Q4 FY26

3 Despite an unfavorable product mix and lower exports, EBITDA margins were maintained at 19% in H1

8 ‹#›

Financial Highlights

Total Income (In Cr.)

EBITDA & Margins (%)

PAT & Margins (%)

17.4 %

312

366

20.1 %

18.8 %

11.6 %

11.3 %

9.6%

14.6 %

H1FY25

H1FY26

H1FY25

H1FY26

H1FY25

H1FY26

Total Income (In Cr.)

EBITDA & Margins (%)

PAT & Margins (%)

5.6 %

178

188

19.5 %

18.1 %

11.9 %

10.9 %

-1.8%

-3.2 %

6 2 Y F 1 H

6 2 Y F 2 Q

Q1FY26

Q2FY26

Q1FY26

Q2FY26

Q1FY26

Q2FY26

9 ‹#›

H1 & Q2 FY26 Financial Performance

Particulars (Rs Cr)

Q2FY26

Q1FY26

Revenue from Operations

Other Income

Total Income

Total Expenditure

EBITDA

EBITDA Margin %

Depreciation

Profit Before Interest & Tax

Interest

Profit Before Tax

Tax

Net Profit

PAT Margin (%)

Diluted Earnings Per Share (Rs)

182.8

5.4

188.2

154.2

34.0

18.1%

3.9

30.2

2.5

27.7

7.3

20.4

10.9%

1.01

173.1

5.1

178.2

143.5

34.7

19.5%

3.6

31.0

2.6

28.5

7.3

21.1

11.9%

1.05

QoQ

5.6%

6.2%

5.6%

7.4%

-1.8%

-137bps

6.1%

-2.7%

-3.7%

-2.7%

-1.0%

-3.2%

-100bps

H1FY26

H1FY25

355.9

10.5

366.4

297.7

68.7

18.8%

7.5

61.2

5.0

56.2

14.6

41.6

11.3%

2.06

307.2

4.9

312.1

249.4

62.7

20.1%

5.0

57.7

8.0

49.7

13.5

36.3

11.6%

1.89

YoY

15.8%

114.5%

17.4%

19.4%

9.6%

-134bps

50.7%

6.0%

-37.3%

13.0%

8.5%

14.6%

-27bps

10 ‹#›

Revenue By Segment

Q2FY26

Q1FY26

By Line of Business

By End Users Industries

By Geography

35.3%

39.0%

183

25.7%

7.3%

11.8%

183

81.0%

2.5%

183

97.5%

24.9%

31.2%

43.9%

173

10.2%

9.5%

173

80.3%

4.0%

173

96.0%

Q2FY25

15.2%

165

56.8%

28.1%

13.3%

9.9%

165

76.8%

6.1%

165

93.9%

Rs Cr

Reaction Systems

Storage, Separation & Drying Systems

Plant, Engineering Services

Pharmaceuticals

Chemicals

Others

Domestic

Exports

11 ‹#›

QUARTER PERFORMANCE- Q2FY26

BUSINESS OVERVIEW

ANNEXURE

1212

Standard Glass Lining: A Top Ranked Specialised Engineering Equipment Company

Leading manufacturers of glass-lined, stainless steel, and nickel alloy based specialized engineering equipment

Well invested manufacturing facility with strong capabilities across chain

Deep and well-established customer relationship

Strong Distribution and Sales Network

37%

42%

19%

11%

11,000+

$108bn

Rs. 195 Cr

Total Revenue CAGR from FY22-25

EBITDA CAGR from FY22-25

EBITDA margins in FY25

PAT margins in FY25

Manufacturing facilities

Products delivered to customers

Large export opportunity; Global TAM

Healthy Cash in the books; Net Debt free Status

‹#›

Diversified and De-Risked Business Model

FY23

7.8%

FY24

13.2%

FY25

13.2%

31.0%

498

61.3%

544

30.1%

56.7%

614

52.3%

34.5%

Rs Cr

H1FY26

30.2%

41.4%

356

28.4%

8.7%

10.7%

356

Reaction Systems

Storage, Separation & Drying Systems

Plant, Engineering Services

Pharmaceuticals

Chemicals

Others

Domestic

Exports

14 ‹#›

14.3%

2.9%

12.5%

5.7%

498

82.8%

0.3%

498

99.7%

544

81.8%

0.4%

544

99.6%

12.2%

12.3%

614

3.7%

614

96.3%

75.5%

80.6%

3.2%

356

96.8%

By Line of Business

By End Users Industries

By Geography

Strong Growth Trajectory

Total Income (In Cr)

EBITDA & EBITDA Margins

PAT & PAT Margins

CAGR:37%

CAGR:42%

500

550

626

366

242

101

18.4%

120

19.1%

17.3%

17.6%

18.8%

10.4%

CAGR:40%

11.3%

10.7%

10.9%

11.0%

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

EBITDA

Margins

PAT

Margins

15 ‹#›

Well Positioned in a High Growth Market

Reaction Systems (heat transfer systems, pipes & fittings, pumps, reactors)

Separation and Drying Systems (Filtration & Drying, Storage, Vessels)

Plant Engineering and Services (Services, utility systems, others)

7 6 . 1 2

1 7. 4 5

1 4 . 0 0

Global Market CY23 (USD bn)

TAM

1 1 4 . 5 1

3 3 . 1 2

3 0 . 0 0

India Market FY24 (INR bn)

~INR 120–150bn Capital spending in the pharmaceutical industry likely to remain at current levels or increase to INR 120-150 bn per year upto FY27 owing to local export demand & semi- regulated markets

~INR 70 Bn Capex per year of player’s in the Chemical Industry will increase by ~ 7% -to 9% CAGR until FY25-26

China +1 To facilitate robust demand potential from overseas market

16 ‹#›

SGLT-Driving India’s Next CDMO Frontier

CDMO-Fastest-growing segment, reflecting its central role in the evolving global pharma ecosystem

Global Innovator CDMO Market (In US$ Bn)

CAGR: 10%

Rising demand for outsourced drug development driven by cost efficiency, scalability, and faster time-to-market

Indian Innovator CDMO Market without China (In US$ Bn) CAGR: 12%

Development Manufacturing

177

162

147

134

122

Expanding specialty chemical capacity + rising pharma outsourcing = powerful tailwinds for CDMO growth

111

101

Move toward integrated, flexible manufacturing solutions catering to complex drug pipelines and biologics

1.7

1.5

1.3

1.4

1.1

1.2

1.0

3.7

3.4

3.3

3.1

3.0

2.8

2.7

2.4

2.2

1.9

1.7

2024

2025E

2026E

2027E

2028E

2029E

2030E

2031E

2032E

2033E

2034E

Pharma CDMO presents a high-conviction, long-term opportunity fueled by global innovation and supply chain reconfiguration

2024

2025E 2026E

2027E 2028E

2029E 2030E

2031E

2032E 2033E

2034E

SGLT Building the Future of Pharma with Integrated CDMO Capabilities

Backed by a marquee customer base across global pharmaceutical and specialty chemical industries

Strategically expanding into niche, high-growth technology segments, with contributions expected to double in the next five years

Positioned to evolve as a comprehensive CDMO solutions provider

Source- Research Report

17 ‹#›

Business Model built on Multiple USPs

CUSTOMISED AND INNOVATIVE PRODUCT OFFERING

WELL INVESTED MANUFACTURING FACILITIES

DEEP RELATION- -SHIP WITH MARQUEE CLIENTS

INVESTING IN PROJECTS TO DRIVE FUTURE GROWTH

STRATEGIC PARTNERSHIP, AIDING IN STRENGTHENING THE BUSINESS MODEL

PROFITABLE AND SCALABLE BUSINESS MODEL

18 ‹#›

1. Customised and Innovative Product Offering

Vacuum / Pressure

RM Storage

Reaction

Filtration

Drying

Heat Exchanger

Collection of filtrate

Collection of distillate or separate layers

Heating / Cooling System for reaction

Water/Steam based system

Single fluid system

Other multifluid systems

Air Handling / Environment Management

Testing Equipment (Quality Control)

e r o C

e r o c - n o N

Capabilities

1 of the few companies in India offering end- to-end customized solutions

Capability to cater to customized process needs of end-users to deliver large and complex projects with a wide equipment range

Turnkey automated equipment solutions optimising processes like vacuum distillation, solvent recovery, gas dispersion

Delivered some of the largest & most complex equipment in India across Product Portfolio

Capability to manufacture process equipment using various types of alloys with thickness ranging from 1mm to 60 mm used in food, pharma & fine chemical industries

Unique Offerings

STANGLASS

No Stain Glass

Shell & Tube heat exchanger

Smart seal

Clampless Manhole

Extended Nozzles

Contributing to its leadership position

TOP 3 Process equipment manufacturers in the Pharma Industry*^

“Key Supplier” Of GMP-compliant accessories for stainless steel GLE^

TOP 3 Suppliers of multistage claw vacuum pumps in India *^

TOP 3 Stainless steel & Nickel - alloy based specialized engineering equipment for India’s Pharma & Chemical sectors*

TOP 3 with 23.3% market share Suppliers of PTFE lined pipelines and fittings in India through acquisition of the business of M/S Yashave Glass Lining Industries, M/S Higenic Flora Polymers*^

Acquired Scigenics (India) Private Limited and proposed acquisition of C2C Engineering Private Limited

Created strong brand equity through decades of industry expertise, technology prowess, innovative product offerings, high-reliability solutions, and the ability to deliver value to customers

*In terms of revenue in Fiscal 24. ^Source- F&S Report

GL – Glass Lined Source- F&S Report

19 ‹#›

2. Well Invested Manufacturing Facilities

Turkey

Bangladesh

Dubai

Egypt

Malaysia

Nigeria

Sri Lanka

Singapore

Worldwide Presence

8 Manufacturing Facilities- SGL Unit, S2 Unit 1, S2 Unit 5, S2 Unit 3, S2 Unit 4, SFPL Unit, CPK Unit 1, CPK Unit2

1 Manufacturing Facilities in Chennai- Standard Sygenics private limited

9 # of Mfg. Facilities

65 Sub products across product categories

30 ANFD capacity p.m.

30L to 40,000L Capability to mfg. products of varied sizes

>500,000 Built-up area (sq. ft.)

9,000 units PTFE lined pipes & fittings capacity p.m.

100 Reactors p.m.

300-350 units Monthly Capacity across product portfolio

20 ‹#›

3. Deep Relationship with Marquee Clients add more customers

Revenue Contribution from Top 10 & Top 20 Customers

Top 10 customer

Top 20 customer

72%

54%

58%

41%

59%

45%

61%

45%

FY23

FY24

FY25

H1FY26

Enjoying long-standing relationships in excess of 3 years with 13 of our top 20 customers

Long-term relationships ongoing engagements with customers allow to plan Capex and enhance ability to benefit from increasing economies of scale

and

21 ‹#›

4. Investing in Projects to Drive Future Growth

Planned Capex: ₹130 Crs over the next 2-3 Years; Total expansion of 5.5 lakh sq. ft.

We have invested significant capex in the past to expand our manufacturing capacities

35%

Capex (INR Cr)

% of Capex to revenue

5.0%

6.0%

6.9%

4.7%

4.6%

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

Intend to expand our manufacturing capacities for existing products to cater to the growing demand from our existing customers and to meet requirements of new customers

upto ₹400mn

Net Proceeds towards expansion of our existing manufacturing units and upcoming facilities

Propose to purchase new machineries and equipment to build-up additional capacity for our glass lining and stainless steel and nickel alloy equipment operations namely:

Welding Machines

Cranes

Laser Scanning cutting Machines

Addition of new facility

Installation of new Machinery

Increase production capacity

Scale operations

Onboard new customers

Introduce new products

Better serve existing customers

Reduced delivery time  Increase orders in hand

22 ‹#›

5. Strategic Partnership

Grow inorganically through strategic acquisitions and alliances

Agreement with HHV Pumps for supply of vacuum pumps with a private label arrangement.

Growth aided by other inorganic acquisitions

M/s S2 Engineering Services (metals business)

M/s Stanpumps Engineering Industries (pumps business)

C.P.K Engineers Private Limited (compliment existing capabilities)

Proposed Acquisition of C2C Engineering Private Limited (multidisciplinary engineering expertise)

Acquired the business of firms engaged in the business of manufacturing, supply,installation and repair of PTFE lined pipes and fittings

M/s Higenic Flora Polymers

M/s Yashasve Glass Lining Industries

Scigenics (India) Private Limited

A sale and purchase agreement for supply of certain grades of glass used by our glass lining division

Asahi Glassplant Inc.

GL Hakko

Plan to target entities that expand our opportunities in:-

Other end-markets

Geographic regions

New customers

New products

Strategic Partnership with Japan’s AGI Group to Launch World’s First Glass-Lined Shell and Tube Heat Exchangers in India

23 ‹#›

6. Profitable and Scalable Business Model

ROE/Adjusted ROE*

ROCE/Adjusted ROCE*

Total debt/Equity and Net debt/Equity

ROE

Adjusted ROE

56.2%

54.9%

50.0%

47.6%

28.5%

20.7%

18.2%

18.5%

11.6%

11.3%

ROCE

Adjusted ROCE

1.01

0.98

42.5%

42.0%

44.1%

43.4%

29.4%

25.5%

23.8%

22.2%

19.0%

16.0%

0.53

0.47

0.32

0.18

0.10

0.0

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

Total Debt to Equity

Net Debt to Equity

* Adjusted RoE and ROCE are calculated on average Net worth and Capital Employed net of cash. Note- ROE, Adjusted ROE, ROCE and Adjusted ROCE for H1 FY26 are Annualised

24 ‹#›

Improving Working Capital and Strong Asset TO

W o r k i n g C a p i t a l D a y s

F i x e d A s s e t T u r n o v e r R a t i o ( x )

Receivable Days

Inventory Days

Payables Days WC Days

174

131

123

110

123

116

103

10.9

8.4

7.4

6.0

5.3

FY22

FY23

FY24

FY25

H1FY26

FY22

FY23

FY24

FY25

H1FY26

25 ‹#›

Strategic Priorities

Continue to expand and improve our existing product portfolio and enter into additional end-user industries

Capitalise on increasing demand from international markets to grow our exports

Continue to strengthen our existing product portfolio in line with our capabilities

Increasing the share of revenues from international markets

Diversify into products with prospects for increased growth and profitability

Consolidate certain of our existing facilities to achieve cost efficiencies

Continue to pursue new products within existing segments + explore the use of engineering capabilities to diversify product offerings, especially in products from related segments

Grow inorganically through strategic acquisitions and alliances

Explore & consider opportunities that can create synergies between the proposed target companies and us, and align with our growth strategy

Propose to enter into additional end-user industries

Oil & Gas

Heavy Engineering

Edible Oil

Flavours & Fragrance

Paints & Coatings

Plan to target entities that expand our opportunities in:-

Expand our team to expand our sales and marketing reach will allow us to target newer customers in Southern & Western regions of India

Other end-markets

Geographic regions

New customers

New products

26 ‹#›

QUARTER PERFORMANCE- Q2FY26

BUSINESS OVERVIEW

ANNEXURE

2727

From Vision to Reality: Our Company's Journey

Incorporated the Glass Lining Division

Sold 100 glass lined reactors.

Supplied first unique stainless-steel glass lined reactor to NATCO Pharma Limited

Hit a turnover of ₹ 500,000,000.00

Finished construction of new facility of glass lining equipment at SGL Unit

Our Material Subsidiary acquired metal business from M/s S2 Engineering Services and pumps business from M/s Stanpumps Engineering Industries

Our Material Subsidiary was incorporated as a wholly-owned subsidiary

2013

2014

2025

2016

2024

2018

2019

2021

2023

• Successful IPO; • Launch of Glass Lined Shell and Tube Heat

Exchangers,

• Operation Commenced at Unit 5, Supply and Purchase

•

agreement with Gale Process Solutions LLP, USA Incorporation of wholly owned subsidiary- Standard Engineering Inc.

• Long-term agreement with M/s. Biocon Solutions Pte

Ltd, Singapore to expand market access across Southeast Asia.

• Proposed for New Name and Change in Object:

Standard Engineering Technology Limited.

• Proposed Acquisition of C2C Engineering Private

Limited

• Acquisition with Scigenics (India) Private Limited.

Acquired the business of Hyderabad based C.P.K. Engineers Private Limited

Resale arrangements for North America (excluding Cuba), South America, Europe (excluding Belarus and Russia) and certain countries in Asia and Africa

• Investment from AGI Investors

(Japan) in our Company

• Acquired the business of M/s Higenic Flora Polymers & M/s Yashasve Glass Lining

2022

Agreement with Climaveneta Climate Technologies Private Limited to enter the chillers market

28 ‹#›

Global Industry Growth Driving Expansion

The Global Market Opportunity –Sizing (Values in USD Bn) and CAGR (2023 – 2028E), unless specified otherwise

Glass Lined Equipment Market

Reactors (Pressure Vessels) & Storage Tanks Market

Filter & Dryers Market Overview

CAGR 10.1%

3.4

2.1

Pressure Vessels

CAGR 4.0%

70.1

58.0

Storage Tanks

CAGR 7.6%

23.1

CAGR 8.7%

2.12

16.0

1.40

2023

2028F

2023

2028F

2023

2028F

2023

2028F

Vacuum Pumps Market Overview

High-Alloy Steel & PTFE lines pipes & Fittings Market

Heat Exchangers Market Overview

CAGR 4.9%

6.6

5.2

High Alloy Steel

CAGR 5.6%

12.5

9.5

PTFE (USD mn)

CAGR 5.0%

255

200

CAGR 5.8%

16.8

12.7

2023

2028F

2023

2028F

2023

2028F

2023

2028F

Source- F&S Report

29 ‹#›

India's Expanding Industry Creating Massive Growth Opportunities for the Company

The India Market Opportunity –Sizing (Values in INR Billion) and CAGR (FY24 –FY29E), unless specified otherwise

Glass Lined Equipment Market

CAGR 10.1%

18.6

11.5

FY24

FY29F

Vacuum Pumps Market Overview

CAGR 10.1%

23.8

14.7

Reactors (Pressure Vessels and Storage tanks) Market Overview

CAGR 6.7%

95.1

68.7

Filter & Dryers Market Overview

* CAGR is from FY23-FY28F

CAGR 11.9%*

15.8

9.0

FY24

FY29F

FY24E

FY29F

High-Alloy Steel & PTFE lines pipes & Fittings Market

Heat Exchangers Market Overview

High Alloy Steel

CAGR 7.4%*

680

PTFE (INR mn)

CAGR 10.3%

1,820.4

CAGR 9.0%

83.0

1,230.0

54.0

280

FY24E

FY29F

FY24

FY28F

FY24

FY28F

FY24E

FY29F

30 ‹#›

Source- F&S Report

A Glimpse of our Plant

31 ‹#›

Well Diversified Product Portfolio

Reaction Systems (heat transfer systems, pipes & fittings, pumps, reactors)

Separation and Drying Systems FRP Moulded Gratings (Filtration & Drying, Storage, Vessels)

Plant Engineering and Services (Services, utility systems, others)

FRP Rods

AE Reactor

BE Reactor

CE Reactor

Receivers

Heat Exchanger

Pumps

Storage Tank

Conical Dryer

32 ‹#›

Introducing our Leadership Team

Senior Management Personnel

Kandula Nageswara Rao Promoter and Managing director

Kandula Krishna Veni Promoter and Executive Director

Kandula Ramakrishna Promoter and Executive Director

Venkata Mohana Rao Katragadda Promoter and Executive Director

Yasuyuki Ikeda Non-Executive Director (Nominee of AGI Investors)

Kallam Hima Priya Company Secretary & Compliance officer

Anjaneyulu Pathuri Chief Financial Officer

Kudaravalli Punna Rao Executive Vice President, Manufacturing

Palayil Nanda Kumar Chief Marketing Officer – South India

Bhanu Prakash Kandula Vice President, Manufacturing

Vara Prasad Vice President - Operations

Somanchi Datta Phani Prabhakar General Manager - Projects

Radhakrishna Bandi Asst. General Manager- Purchase

Sambasiva Rao Gollapudi Non-Executive Chairman, Independent Director & Audit Committee Chairman

Sudhakara Reddy Siddareddy Independent Director

Radhilka Nannapaneni Independent Director

33 ‹#›

Historical Profit and Loss Statement

Particulars (All amounts are in INR Cr. except otherwise stated)

Revenue from Operations

Other Income

Total Income

COGS

Gross Profit

Total Expenditure

EBITDA

EBITDA Margins (%)

Depreciation

Profit Before Interest & Tax

Interest

Profit Before Tax (PBT)

Tax

Net Profit

Net Profit Margins (%)

Diluted Earnings Per share (Rs.)

FY23

497.6

2.5

500.1

285.5

214.6

411.8

88.3

17.6%

7.7

80.5

8.7

71.9

18.4

53.4

10.7%

3.5

FY24

543.7

6.0

549.7

317.7

232.0

448.8

100.9

18.4%

9.3

91.6

11.8

79.8

19.8

60.0

10.9%

3.5

FY25

613.7

12.3

626.0

344.3

281.7

506.2

119.7

19.1%

11..1

108.7

15.1

93.5

24.9

68.6

11.0%

3.5

H1FY26

355.9

10.5

366.4

188.5

177.8

297.7

68.7

18.8%

7.5

61.2

5.0

56.2

14.6

41.6

11.3%

2.1

34 ‹#›

Historical Balance Sheet

Particulars

Equity

Equity share capital

Other equity

Non-controlling interests

Total Equity

Non-current liabilities

Financial liabilities

(a) Borrowings

(b) Lease liabilities

Provisions

Deferred tax liabilities (net)

Total Non-Current Liabilities

Current liabilities

Short term borrowings

Trade payables

Short terms Provisions

Other current liabilities

Total Current Liabilities

Total Equity and Liabilities

FY23

FY24

FY25

H1FY26

Particulars

FY23

FY24

FY25

H1FY26

15.8

139.9

155.7

3.0

18.5

2.1

0.6

24.2

57.0

75.0

0.8

35.1

167.9

347.8

18.2

389.2

1.6

409.0

0.6

12.4

0.9

0.6

14.5

113.2

88.7

0.9

39.1

241.9

665.4

199.5

507.3

5.9

712.7

2.0

22.6

1.1

1.3

26.9

37.1

108.2

1.5

71.9

218.7

958.4

199.5

548.4

6.5

754.3

1.8

19.6

1.1

1.2

23.6

108.9

143.9

2.2

121.1

376.1

Non-Current Assets

Property plant and equipment

Capital work-in-progress

Right-of-use assets

Goodwill

Other intangible assets

Financial assets

(a) Loans

(b) Other financial assets

Income tax asset (net)

Other non-current assets

Total Non-Current Assets

Current Assets

Inventories

Financial assets

(a) Trade receivables

(b) Cash and cash equivalents

(d) Other financial assets

Other current assets

Total Current Assets

1,154.1

Total Assets

54.7

3.3

19.7

0.6

2.1

0.7

3.5

82.2

4.5

13.0

1.0

1.4

4.6

84.7

106.6

101.0

112.4

8.5

26.2

7.7

1.0

2.0

13.9

160.3

9.7

23.4

7.7

0.9

29.9

9.3

193.4

143.4

224.8

279.3

363.6

91.3

5.4

5.2

17.8

263.1

347.8

154.8

15.4

36.5

95.5

31.7

558.8

665.4

214.0

1.7

119.9

145.9

37.3

798.1

958.4

235.8

3.3

16.9

268.4

72.8

960.7

1,154.1

35 ‹#›

*All amounts are in INR Cr except otherwise stated

Thank You

Investor Relations Contact: Go India Advisors LLP

Monali Jain Go India Advisors monali@GoIndiaAdvisors.com M:+91 8078675682

Prayasi Patel Go India Advisors prayasi@GoIndiaAdvisors.com M:+91 9653602085

Company Contact:

Anjaneyulu Pathuri Chief Financial Officer (CFO) anjaneyulu@standardglr.com Standard Glass Lining Technology Limited

Hima Priya Kallam Company Secretary cshima@standardglr.com Standard Glass Lining Technology Limited

Company’s Investor Relations investorrelations@standardglr.com Standard Glass Lining Technology Limited

3636

← All Transcripts SETL Stock Page →

Standard Glass Lining Technology Limited has informed the Exchange about Investor Presentation

Market Movers